Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   GASTROENTEROLOGY AND HEPATOLOGY FROM BED TO BENCH   2016 , Volume 9 , Number 3; Page(s) 158 To 173.
 
Paper: 

METABOLOMIC ANALYSIS OF HUMAN CIRRHOSIS, HEPATOCELLULAR CARCINOMA, NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS DISEASES (REVIEW ARTICLE)

 
 
Author(s):  SAFAEI AKRAM, AREFI OSKOUIE AFSANEH, MOHEBBI SEYED REZA, REZAEI TAVIRANI MOSTAFA, MAHBOUBI MOHAMMAD, PEYVANDI MARYAM, OKHOVATIAN FARSHAD, ZAMANIAN AZODI MONA*
 
* PROTEOMICS RESEARCH CENTER, SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES, TEHRAN, IRAN
 
Abstract: 

Metabolome analysis is used to evaluate the characteristics and interactions of low molecular weight metabolites under a specific set of conditions. In cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH) the liver does not function thoroughly due to long-term damage. Unfortunately the early detection of cirrhosis, HCC, NAFLD and NASH is a clinical problem and determining a sensitive, specific and predictive novel method based on biomarker discovery is an important task. On the other hand, metabolomics has been reported as a new and powerful technology in biomarker discovery and dynamic field that cause global comprehension of system biology. In this review, it has been collected a heterogeneous set of metabolomics published studies to discovery of biomarkers in researches to introduce diagnostic biomarkers for early detection and the choice of patient-specific therapies.

 
Keyword(s): CIRRHOSIS, HCC, NAFLD, NASH, METABOLOMICS
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
 
+ Click to Cite.
APA: Copy

SAFAEI, A., & AREFI OSKOUIE, A., & MOHEBBI, S., & REZAEI TAVIRANI, M., & MAHBOUBI, M., & PEYVANDI, M., & OKHOVATIAN, F., & ZAMANIAN AZODI, M. (2016). METABOLOMIC ANALYSIS OF HUMAN CIRRHOSIS, HEPATOCELLULAR CARCINOMA, NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS DISEASES (REVIEW ARTICLE). GASTROENTEROLOGY AND HEPATOLOGY FROM BED TO BENCH, 9(3), 158-173. https://www.sid.ir/en/journal/ViewPaper.aspx?id=510019



Vancouver: Copy

SAFAEI AKRAM, AREFI OSKOUIE AFSANEH, MOHEBBI SEYED REZA, REZAEI TAVIRANI MOSTAFA, MAHBOUBI MOHAMMAD, PEYVANDI MARYAM, OKHOVATIAN FARSHAD, ZAMANIAN AZODI MONA. METABOLOMIC ANALYSIS OF HUMAN CIRRHOSIS, HEPATOCELLULAR CARCINOMA, NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS DISEASES (REVIEW ARTICLE). GASTROENTEROLOGY AND HEPATOLOGY FROM BED TO BENCH. 2016 [cited 2021September20];9(3):158-173. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=510019



IEEE: Copy

SAFAEI, A., AREFI OSKOUIE, A., MOHEBBI, S., REZAEI TAVIRANI, M., MAHBOUBI, M., PEYVANDI, M., OKHOVATIAN, F., ZAMANIAN AZODI, M., 2016. METABOLOMIC ANALYSIS OF HUMAN CIRRHOSIS, HEPATOCELLULAR CARCINOMA, NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS DISEASES (REVIEW ARTICLE). GASTROENTEROLOGY AND HEPATOLOGY FROM BED TO BENCH, [online] 9(3), pp.158-173. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=510019.



 
  pdf-File
Yearly Visit 54
 
 
Latest on Blog
Enter SID Blog